Explore

Rapid Read Rapid Read
FDA Initiates Safety Study on Mifepristone Amid Legal Challenges

FDA Initiates Safety Study on Mifepristone Amid Legal Challenges

The Food and Drug Administration (FDA) has commenced a safety study of the abortion pill Mifepristone, a move that could lead to restrictions on its distribution by the Trump administration. This development follows a Supreme Court decision in May that allowed the continued prescription of the pill via telemedicine and mail, despite ongoing legal challenges from Louisiana. The study, supported by the White House, is expected to last six months and aims to withstand legal scrutiny. Mifepristone is a key component in medical abortions, which account for a significant portion of abortion procedures in the U.S.
Reuters Reuters
FDA launches study of abortion pill safety, WSJ reports

FDA launches study of abortion pill safety, WSJ reports

(Fixes typo in paragraph 6) June 5 (Reuters) - The FDA has launched a safety study of the abortion pill, also called mifepristone, a step that could pave the way for the Trump administration to restrict how it is distributed and used, the Wall Street Journal reported on Thursday.
Rapid Read Rapid Read
Supreme Court Decision Allows Alabama to Eliminate Majority-Black Congressional District

Supreme Court Decision Allows Alabama to Eliminate Majority-Black Congressional District

The Supreme Court of the United States (SCOTUS) has lifted a lower-court order that blocked Alabama's 2023 congressional map, which was challenged for diluting Black votes. This decision follows a similar ruling regarding Louisiana, where the court found that creating a second majority-Black district was unconstitutional. The 6-3 decision, along ideological lines, allows Alabama to proceed with a map that could give Republicans a 6-1 advantage in the state's U.S. House delegation. The ruling has significant implications for the current Alabama 2nd Congressional District, held by Black Representative Shomari Figures, which may be dramatically altered, potentially affecting his re-election prospects.
Rapid Read Rapid Read
New Warnings Issued Over Controversial Supplement Kratom Amid Rising Health Concerns

New Warnings Issued Over Controversial Supplement Kratom Amid Rising Health Concerns

Concerns are mounting over the use of Kratom, a controversial supplement that remains legal in most parts of the United States. The Centers for Disease Control and Prevention (CDC) has reported an increase in calls to poison control centers related to Kratom use. This has prompted new warnings about the potential health risks associated with the supplement. Kratom is often marketed as a natural remedy for pain and anxiety, but its safety and efficacy are under scrutiny. NBC News highlighted the story of a woman who sought professional help to quit using Kratom, underscoring the challenges faced by users.
Rapid Read Rapid Read
Congressman Tom Cole Supports Agriculture Funding Bill Benefiting Farmers and Rural Communities

Congressman Tom Cole Supports Agriculture Funding Bill Benefiting Farmers and Rural Communities

Congressman Tom Cole of Oklahoma's Fourth District has voted in favor of H.R. 8646, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for Fiscal Year 2027. This legislation provides funding for the United States Department of Agriculture, the Food and Drug Administration, and the Commodity Future Trading Commission. The bill aims to support American farmers, ranchers, and rural communities by investing in agricultural research, food safety, and infrastructure development. It also emphasizes national security by tightening oversight on foreign purchases of agricultural land. Congressman Cole highlighted the importance of the bill in reinforcing 'America First' principles and ending certain Biden-era regulations.
Trendline Trendline
FDA Approves Amneal's Romidepsin Injection, Boosting Oncology Portfolio

FDA Approves Amneal's Romidepsin Injection, Boosting Oncology Portfolio

FDA Approves Amneal's Romidepsin Injection, Boosting Oncology Portfolio
Rapid Read Rapid Read
Congressman Riley Moore Praises House Approval of FY27 Agriculture-FDA Funding Bill, Highlighting Spending Cuts

Congressman Riley Moore Praises House Approval of FY27 Agriculture-FDA Funding Bill, Highlighting Spending Cuts

Congressman Riley M. Moore has expressed approval following the House's passage of the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for Fiscal Year 2027. This legislation, known as H.R. 8646, aims to provide essential funding for agricultural and public health needs while reducing federal spending by $380 million compared to the previous fiscal year. The act allocates $22.5 billion to the U.S. Department of Agriculture and $7.1 billion to the FDA, with significant funding directed towards programs like WIC and SNAP. Additionally, Moore highlighted nearly $3 million in Community Project Funding secured for two initiatives in West Virginia, which are designed to enhance local infrastructure and emergency response capabilities. The bill will now move to the Senate for further consideration.
Trendline Trendline
Patent Laws Delay Generic Ozempic Availability in the U.S., Impacting Diabetes Patients

Patent Laws Delay Generic Ozempic Availability in the U.S., Impacting Diabetes Patients

Patent Laws Delay Generic Ozempic Availability in the U.S., Impacting Diabetes Patients
Vox Vox
How Americans got hooked on “drive-thru” healthcare

How Americans got hooked on “drive-thru” healthcare

When did getting a prescription start to feel like ordering at McDonald’s?
Vox Vox
How Trump is justifying new tariffs

How Trump is justifying new tariffs

The Trump administration's newfound concern for forced labor, briefly explained.
Trendline Trendline
Terremoto Biosciences Receives FDA Fast Track Designation for Breast Cancer Drug TER-2013

Terremoto Biosciences Receives FDA Fast Track Designation for Breast Cancer Drug TER-2013

Terremoto Biosciences Receives FDA Fast Track Designation for Breast Cancer Drug TER-2013
Rapid Read Rapid Read
Survey Reveals Majority of Americans Believe Supreme Court Favors President Trump

Survey Reveals Majority of Americans Believe Supreme Court Favors President Trump

A recent survey conducted by Marquette Law School indicates that a significant portion of the American public perceives the U.S. Supreme Court as favoring President Donald Trump in its rulings. The poll, conducted in May, reveals that approximately 60% of adults believe the court rules in favor of Trump 'almost always' or 'most of the time.' This perception persists despite the court's February decision to reject Trump's sweeping tariffs, a key component of his economic agenda. The court has, however, allowed several of Trump's controversial policies to proceed while under litigation, including the termination of federal spending and deportation protections, and a ban on transgender military service. The survey also highlights public opinion on upcoming court decisions, such as Trump's executive order on birthright citizenship and his influence over independent agencies.